• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Thresholds for normal blood pressure and serum cholesterol.正常血压和血清胆固醇的阈值。
BMJ. 2005 Jun 25;330(7506):1461-2. doi: 10.1136/bmj.330.7506.1461.
2
Revise your goals for heart health. Match your cholesterol profile and other data against new guidelines.修订你的心脏健康目标。将你的胆固醇状况及其他数据与新指南进行比对。
Heart Advis. 2004 Nov;7(11):1, 7.
3
[An epidemiological study of risk indicators for cardiovascular diseases (EPOZ). I. Blood pressure, serum cholesterol level, Quetelet-index and smoking habits in an open population aged 5 years and older].[心血管疾病风险指标的流行病学研究（EPOZ）。I. 5岁及以上开放人群的血压、血清胆固醇水平、体重指数和吸烟习惯]
Ned Tijdschr Geneeskd. 1980 Feb 9;124(6):183-9.
4
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.根据个体的绝对心血管风险，使用药物降低血压和血液胆固醇。
Lancet. 2005;365(9457):434-41. doi: 10.1016/S0140-6736(05)17833-7.
5
Criteria for considering people at risk for cardiovascular disease prevention; guidelines of the Joint British Societies of cardiovascular disease in clinical practice.
Ann Clin Biochem. 2007 Mar;44(Pt 2):196. doi: 10.1258/000456307780117984.
6
[Effects of health examination and follow-up educational programs on awareness and modification of risk factors for cardiovascular disease in a Japanese urban population].[健康检查和后续教育项目对日本城市人群心血管疾病危险因素认知及改变的影响]
Nihon Koshu Eisei Zasshi. 1997 Jun;44(6):440-9.
7
A supermarket cardiovascular screening program: analysis of participants' solicitation of follow-up care.一项超市心血管筛查项目：参与者后续护理需求分析
Am J Prev Med. 1994 Sep-Oct;10(5):283-9.
8
Thresholds for conventional and home blood pressure by sex and age in 5018 participants from 5 populations.来自5个群体的5018名参与者按性别和年龄划分的常规血压和家庭血压阈值。
Hypertension. 2014 Oct;64(4):695-701. doi: 10.1161/HYPERTENSIONAHA.114.03839. Epub 2014 Jun 30.
9
Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.收缩压和总胆固醇对心血管疾病风险的联合作用。
Circulation. 2005 Nov 29;112(22):3373-4. doi: 10.1161/CIRCULATIONAHA.105.581934.
10
Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region.亚太地区收缩压和血清胆固醇对心血管疾病的联合影响。
Circulation. 2005 Nov 29;112(22):3384-90. doi: 10.1161/CIRCULATIONAHA.105.537472. Epub 2005 Nov 21.

引用本文的文献

1
How Genes Modulate Patterns of Aging-Related Changes on the Way to 100: Biodemographic Models and Methods in Genetic Analyses of Longitudinal Data.基因如何在迈向百岁人生的过程中调节衰老相关变化模式：纵向数据遗传分析中的生物人口统计学模型与方法
N Am Actuar J. 2016;20(3):201-232. doi: 10.1080/10920277.2016.1178588. Epub 2016 Jun 22.
2
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.运动与药物干预对死亡率影响的比较效果：元流行病学研究
Br J Sports Med. 2015 Nov;49(21):1414-22. doi: 10.1136/bjsports-2015-f5577rep.
3
How the effects of aging and stresses of life are integrated in mortality rates: insights for genetic studies of human health and longevity.衰老效应与生活压力如何体现在死亡率中：对人类健康和长寿基因研究的启示
Biogerontology. 2016 Feb;17(1):89-107. doi: 10.1007/s10522-015-9594-8. Epub 2015 Aug 18.
4
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.运动和药物干预对死亡率结局的比较效果：荟萃流行病学研究。
BMJ. 2013 Oct 1;347:f5577. doi: 10.1136/bmj.f5577.
5
Prevalence of polypharmacy and drug interaction among hospitalized patients: opportunities and responsabilities in pharmaceutical care.住院患者多重用药及药物相互作用的患病率：药学服务中的机遇与责任
Mater Sociomed. 2012;24(2):68-72. doi: 10.5455/msm.2012.24.68-72.
6
Big pharma: a story of success in a market economy.大型制药公司：市场经济中的成功故事。
Med Health Care Philos. 2013 May;16(2):305-9. doi: 10.1007/s11019-012-9384-x.
7
Genetic model for longitudinal studies of aging, health, and longevity and its potential application to incomplete data.衰老、健康和长寿纵向研究的遗传模型及其在不完整数据中的潜在应用。
J Theor Biol. 2009 May 7;258(1):103-11. doi: 10.1016/j.jtbi.2009.01.023. Epub 2009 Feb 4.
8
Can individuals with a significant risk for cardiovascular disease be adequately identified by combination of several risk factors? Modelling study based on the Norwegian HUNT 2 population.通过多种风险因素的组合能否充分识别出心血管疾病高风险个体？基于挪威HUNT 2人群的建模研究。
J Eval Clin Pract. 2009 Feb;15(1):103-9. doi: 10.1111/j.1365-2753.2008.00962.x.
9
Model of hidden heterogeneity in longitudinal data.纵向数据中的隐藏异质性模型。
Theor Popul Biol. 2008 Feb;73(1):1-10. doi: 10.1016/j.tpb.2007.09.001. Epub 2007 Sep 18.
10
The Quality and Outcomes Framework: what have you done to yourselves?质量与结果框架：你们对自己做了什么？
Br J Gen Pract. 2007 Jun;57(539):435-7.

本文引用的文献

1
Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. A descriptive epidemiological study.临床实践中实施欧洲心血管疾病预防指南引发的伦理困境。一项描述性流行病学研究。
Scand J Prim Health Care. 2004 Dec;22(4):202-8. doi: 10.1080/02813430410006693.
2
Atenolol in hypertension: is it a wise choice?阿替洛尔用于治疗高血压：这是一个明智的选择吗？
Lancet. 2004;364(9446):1684-9. doi: 10.1016/S0140-6736(04)17355-8.
3
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.欧洲临床实践中心血管疾病预防指南。欧洲及其他学会心血管疾病预防临床实践联合工作组第三次报告
Eur Heart J. 2003 Sep;24(17):1601-10. doi: 10.1016/s0195-668x(03)00347-6.
4
Is opportunistic disease prevention in the consultation ethically justifiable?在诊疗过程中预防机会性疾病在伦理上是否合理？
BMJ. 2003 Aug 30;327(7413):498-500. doi: 10.1136/bmj.327.7413.498.
5
General practice workload implications of the national service framework for coronary heart disease: cross sectional survey.《国家冠心病服务框架对全科医疗工作量的影响：横断面调查》
BMJ. 2001 Aug 4;323(7307):269-70. doi: 10.1136/bmj.323.7307.269.
6
Preventing cardiovascular disease in primary care.在初级保健中预防心血管疾病。
BMJ. 2001 Aug 4;323(7307):246-7. doi: 10.1136/bmj.323.7307.246.
7
Open letter disputes WHO hypertension guidelines.公开信对世界卫生组织高血压指南提出质疑。
BMJ. 1999 Apr 3;318(7188):893B. doi: 10.1136/bmj.318.7188.893b.
8
Communicating the risk reduction achieved by cholesterol reducing drugs.传达降低胆固醇药物所实现的风险降低情况。
BMJ. 1998 Jun 27;316(7149):1956-8. doi: 10.1136/bmj.316.7149.1956.

Thresholds for normal blood pressure and serum cholesterol.

作者信息

Westin Steinar, Heath Iona

出版信息

BMJ. 2005 Jun 25;330(7506):1461-2. doi: 10.1136/bmj.330.7506.1461.

DOI:10.1136/bmj.330.7506.1461
PMID:15976397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC558444/
Abstract
摘要